Hepatitis C Drug Market Size, Share, Analysis, Trends, Growth, 2032

• Chapter No. 1: Introduction
  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. USP & Key Offerings
  • 1.2. Key Benefits for Stakehulders
  • 1.3. Target Audience
  • 1.4. Report Scope
• Chapter No. 2: Executive Summary
  • 2.1. Key Findings
    • 2.1.1. Top Investment Pockets
      • 2.1.1.1. Market Attractiveness Analysis, By End-User
      • 2.1.1.2. Market Attractiveness Analysis, By Region
  • 2.2. Market Snapshot
  • 2.3. Global Hepatitis C Drug Market, 2016 – 2028 (USD Billion)
  • 2.4. Insights from Primary Respondents
• Chapter No. 3: COVID 19 Impact Analysis
  • 3.1. Impact Assessment of COVID-19 Pandemic, By Region
    • 3.1.1. North America
    • 3.1.2. Europe
    • 3.1.3. Asia Pacific
    • 3.1.4. Latin America
    • 3.1.5. The Middle-East and Africa
  • 3.2. Quarterly Market Revenue and Forecast by Region 2020 & 2021
  • 3.3. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Billion)
  • 3.4. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Billion)
  • 3.5. Key Strategies Undertaken by Companies to Tackle COVID-19
    • 3.5.1. Company Quarterly Revenue Analysis, 2019 & 2020
  • 3.6. Short Term Dynamics
  • 3.7. Long Term Dynamics
• Chapter No. 4: Hepatitis C Drug Market – End-User Segment Analysis
  • 4.1. Overview
    • 4.1.1. Market Revenue Share, By End-User, 2020 & 2028
  • 4.2. Hospitals
    • 4.2.1. Market Size and Forecast, By Region (USD Billion)
    • 4.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.2.3. Key Market Trends, Growth Factors, & Opportunities
  • 4.3. Private labs
    • 4.3.1. Market Size and Forecast, By Region (USD Billion)
    • 4.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.3.3. Key Market Trends, Growth Factors, & Opportunities
  • 4.4. Physician offices
    • 4.4.1. Market Size and Forecast, By Region (USD Billion)
    • 4.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.4.3. Key Market Trends, Growth Factors, & Opportunities
  • 4.5. Public health labs
    • 4.5.1. Market Size and Forecast, By Region (USD Billion)
    • 4.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.5.3. Key Market Trends, Growth Factors, & Opportunities
  • 4.6. Blood Bank
    • 4.6.1. Market Size and Forecast, By Region (USD Billion)
    • 4.6.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.6.3. Key Market Trends, Growth Factors, & Opportunities
  • 5.1. Overview
    • 5.1.1. Global Market Revenue Share, By Region, 2020 & 2028
    • 5.1.2. Global Market Revenue, By Region, 2016 – 2028 (USD Billion)
  • 5.2. North America
    • 5.2.1. North America Market Revenue, By Country, 2016 – 2028 (USD Billion)
    • 5.2.2. North America Market Revenue, By End-User, 2016 – 2028
    • 5.2.5. U.S.
      • 5.2.5.1. U.S. Market Revenue, By End-User, 2016 – 2028
    • 5.2.6. Canada
      • 5.2.6.1. Canada Market Revenue, By End-User, 2016 – 2028
    • 5.2.7. Mexico
      • 5.2.7.1. Mexico Market Revenue, By End-User, 2016 – 2028
  • 5.3. Europe
    • 5.3.1. Europe Market Revenue, By Country, 2016 – 2028 (USD Billion)
    • 5.3.2. Europe Market Revenue, By End-User, 2016 – 2028
    • 5.3.5. Germany
      • 5.3.5.1. Germany Market Revenue, By End-User, 2016 – 2028
    • 5.3.6. France
      • 5.3.6.1. France Market Revenue, By End-User, 2016 – 2028
    • 5.3.7. U.K.
      • 5.3.7.1. U.K. Market Revenue, By End-User, 2016 – 2028
    • 5.3.8. Italy
      • 5.3.8.1. Italy Market Revenue, By End-User, 2016 – 2028
    • 5.3.9. Spain
      • 5.3.9.1. Spain Market Revenue, By End-User, 2016 – 2028
    • 5.3.10. Rest of Europe
      • 5.3.10.1. Rest of Europe Market Revenue, By End-User, 2016 – 2028
  • 5.4. Asia Pacific
    • 5.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2028 (USD Billion)
    • 5.4.2. Asia Pacific Market Revenue, By End-User, 2016 – 2028
    • 5.4.5. China
      • 5.4.5.1. China Market Revenue, By End-User, 2016 – 2028
    • 5.4.6. Japan
      • 5.4.6.1. Japan Market Revenue, By End-User, 2016 – 2028
    • 5.4.7. India
      • 5.4.7.1. India Market Revenue, By End-User, 2016 – 2028
    • 5.4.8. South Korea
      • 5.4.8.1. South Korea Market Revenue, By End-User, 2016 – 2028
    • 5.4.9. South-East Asia
      • 5.4.9.1. South-East Asia Market Revenue, By End-User, 2016 – 2028
    • 5.4.10. Rest of Asia Pacific
      • 5.4.10.1. Rest of Asia Pacific Market Revenue, By End-User, 2016 – 2028
  • 5.5. Latin America
    • 5.5.1. Latin America Market Revenue, By Country, 2016 – 2028 (USD Billion)
    • 5.5.2. Latin America Market Revenue, By End-User, 2016 – 2028
    • 5.5.5. Brazil
      • 5.5.5.1. Brazil Market Revenue, By End-User, 2016 – 2028
    • 5.5.6. Argentina
      • 5.5.6.1. Argentina Market Revenue, By End-User, 2016 – 2028
    • 5.5.7. Rest of Latin America
      • 5.5.7.2. Rest of Latin America Market Revenue, By End-User, 2016 – 20285
  • 5.6. The Middle-East and Africa
    • 5.6.1. The Middle-East and Africa Market Revenue, By Country, 2016 – 2028 (USD Billion)
    • 5.6.2. The Middle-East and Africa Market Revenue, By End-User, 2016 – 2028
    • 5.6.5. GCC Countries
      • 5.6.5.1. GCC Countries Market Revenue, By End-User, 2016 – 2028
    • 5.6.6. South Africa
      • 5.6.6.1. South Africa Market Revenue, By End-User, 2016 – 2028
    • 5.6.7. Rest of Middle-East Africa
      • 5.6.7.1. Rest of Middle-East Africa Market Revenue, By End-User, 2016 – 2028
• Chapter No. 6: Hepatitis C Drug Market – Industry Analysis
  • 6.1. Introduction
  • 6.2. Market Drivers
    • 6.2.1. Driving Factor 1 Analysis
    • 6.2.2. Driving Factor 2 Analysis
  • 6.3. Market Restraints
    • 6.3.1. Restraining Factor Analysis
  • 6.4. Market Opportunities
    • 6.4.1. Market Opportunity Analysis
  • 6.5. Porter’s Five Forces Analysis
  • 6.6. PEST Analysis
  • 6.7. Regulatory Landscape
  • 6.8. Technology Landscape
  • 6.9. Regional Market Trends
    • 6.9.1. North America
    • 6.9.2. Europe
    • 6.9.3. Asia Pacific
    • 6.9.4. Latin America
    • 6.9.5. The Middle-East and Africa
  • 6.10. Pricing Analysis
  • 6.11. Value Chain Analysis
  • 6.12. Downstream Buyers
  • 6.13. Distributors/Traders List
• Chapter No. 7: Competitive Landscape
  • 7.1. Company Market Share Analysis – 2019
    • 7.1.1. Global Hepatitis C Drug Market: Company Market Share, 2019
    • 7.1.2. Global Hepatitis C Drug Market, Company Market Revenue, 2016 – 2019 (USD Billion)
    • 7.1.3. Global Hepatitis C Drug Market, Company Y-o-Y Growth, 2017 – 2028 (%)
    • 7.1.4. Global Hepatitis C Drug Market: Radar Determinant Chart, 2019
  • 7.2. Strategic Developments
    • 7.2.1. Acquisitions & Mergers
    • 7.2.2. New Product Launch
    • 7.2.3. Regional Expansion
  • 7.3. Company Strategic Developments – Heat Map Analysis
• Chapter No. 8: Company Profiles
  • 8.1. Merck & Co
    • 8.1.1. Company Overview
    • 8.1.2. Key Executives
    • 8.1.3. Product Portfolio
    • 8.1.4. Financial Overview
    • 8.1.5. Operating Business Segments
    • 8.1.6. Business Performance
    • 8.1.7. Recent Developments
  • 8.2. Kenilworth
  • 8.3. Roche
  • 8.4. Basel GlaxoSmith
  • 8.5. Gilead Sciences
  • 8.6. AbbVie
  • 8.7. Johnson & Johnson
  • 8.8. Bristul-Myers Squibb
• Chapter No. 9: Marketing Strategy Analysis
  • 9.1. Marketing Channel
  • 9.2. Direct Marketing
  • 9.3. Indirect Marketing
  • 9.4. Marketing Channel Development Trends
  • 9.5. Economic/Pulitical Environmental Change
• Chapter No. 10: Research Methodology
  • 10.1. Research Methodology
  • 10.2. Phase I - Secondary Research
  • 10.3. Phase II - Data Modeling
    • 10.3.1. Company Share Analysis Model
    • 10.3.2. Revenue Based Modeling
  • 10.4. Phase III - Primary Research
  • 10.5. Research Limitations
    • 10.5.1. Assumptions

Table Of Figures

List of Figures 

FIG NO. 1. Market Attractiveness Analysis, By End-User
FIG NO. 2. Market Attractiveness Analysis, By Region
FIG NO. 3. Global Hepatitis C Drug Market Revenue, 2016 – 2028 (USD Billion)
FIG NO. 4. Impact of COVID-19 Pandemic in North America Countries
FIG NO. 5. Market Revenue Share, By End-User, 2020 & 2028
FIG NO. 6. Global Hepatitis C Drug Market for Hospitals, Revenue (USD Billion) 2016 – 2028
FIG NO. 7. Comparative Revenue Analysis of Hepatitis C Drug Market for Hospitals, By Country, 2020 & 2028
FIG NO. 8. Global Hepatitis C Drug Market for Private labs, Revenue (USD Billion) 2016 – 2028
FIG NO. 9. Comparative Revenue Analysis of Hepatitis C Drug Market for Private labs, By Country, 2020 & 2028
FIG NO. 10. Global Hepatitis C Drug Market for Physician offices, Revenue (USD Billion) 2016 – 2028
FIG NO. 11. Comparative Revenue Analysis of Hepatitis C Drug Market for Physician offices, By Country, 2020 & 2028
FIG NO. 12. Global Hepatitis C Drug Market for Public health labs, Revenue (USD Billion) 2016 – 2028
FIG NO. 13. Comparative Revenue Analysis of Hepatitis C Drug Market for Public health labs, By Country, 2020 & 2028
FIG NO. 14. Global Hepatitis C Drug Market for Blood Bank, Revenue (USD Billion) 2016 – 2028
FIG NO. 15. Comparative Revenue Analysis of Hepatitis C Drug Market for Blood Bank, By Country, 2020 & 2028
FIG NO. 16. Global Hepatitis C Drug Market Revenue Share, By Region, 2020 & 2028
FIG NO. 17. North America Hepatitis C Drug Market Revenue, 2016 - 2028 (USD Billion)
FIG NO. 18. Porter’s Five Forces Analysis for Global Hepatitis C Drug Market
FIG NO. 19. PEST Analysis for Global Hepatitis C Drug Market
FIG NO. 20. Pricing Analysis for Global Hepatitis C Drug Market
FIG NO. 21. Value Chain Analysis for Global Hepatitis C Drug Market
FIG NO. 22. Company Share Analysis, 2019
FIG NO. 23. Radar Determinant Chart, 2019
FIG NO. 24. Company Strategic Developments – Heat Map Analysis
FIG NO. 25. Merck & Co  Business Segment Revenue Share, 2020 (%)
FIG NO. 26. Merck & Co  Geographical Segment Revenue Share, 2020 (%)
FIG NO. 27. Market Channels
FIG NO. 28. Marketing Channel Development Trend
FIG NO. 29. Growth in World Gross Product, 2008-2018
FIG NO. 30. Research Methodology – Detailed View
FIG NO. 31. Research Methodology

Table Of Tables

List of Tables 

TABLE NO. 1. Global Hepatitis C Drug Market: Snapshot
TABLE NO. 2. Quarterly Hepatitis C Drug Market Revenue by Region, 2020
TABLE NO. 3. Quarterly Hepatitis C Drug Market Revenue Forecast by Region, 2021
TABLE NO. 4. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Billion) 
TABLE NO. 5. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Billion)
TABLE NO. 6. Global Hepatitis C Drug Market for Hospitals, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 7. Global Hepatitis C Drug Market for Private labs, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 8. Global Hepatitis C Drug Market for Physician offices, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 9. Global Hepatitis C Drug Market for Public health labs, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 10. Global Hepatitis C Drug Market for Others, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 11. Global Hepatitis C Drug Market Revenue, By Region, 2016 – 2028 (USD Billion)
TABLE NO. 12. North America Hepatitis C Drug Market Revenue, By Country, 2016 – 2028 (USD Billion)
TABLE NO. 13. North America Hepatitis C Drug Market Revenue, By End-User, 2016 – 2028 (USD Billion)
TABLE NO. 14. U.S. Hepatitis C Drug Market Revenue, By End-User, 2016 – 2028 (USD Billion)
TABLE NO. 15. Canada Hepatitis C Drug Market Revenue, By End-User, 2016 – 2028 (USD Billion)
TABLE NO. 16. Mexico Hepatitis C Drug Market Revenue, By End-User, 2016 – 2028 (USD Billion)
TABLE NO. 17. Drivers for the Hepatitis C Drug Market: Impact Analysis 
TABLE NO. 18. Restraints for the Hepatitis C Drug Market: Impact Analysis
TABLE NO. 19. Major Buyers of Hepatitis C Drug  
TABLE NO. 20. Distributors/Traders List of Hepatitis C Drug
TABLE NO. 21. Global Hepatitis C Drug Market, Company Market Revenue, 2016 – 2019 (USD Billion)
TABLE NO. 22. Global Hepatitis C Drug Market, Company Y-o-Y Growth, 2017 – 2028 (USD Billion)